Inventor · disambiguated record
Douglas Charles Hanson
Also filed as: HANSON DOUGLAS C · HANSON DOUGLAS CHARLES · HANSON Douglas
12 granted patents·5 pending applications·1,809 citations·filing 1991–2014
95Inventor score
Top patents by PatentIndex Score
17 records- 0198US7824679B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2007·Granted Nov 2, 2010·87 cites·19 claims
- 0298US7411057B2Nucleic acids encoding human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2005·Granted Aug 12, 2008·87 cites·38 claims
- 0398US7132281B2Methods and host cells for producing human monoclonal antibodies to CTLA-4PFIZER·Filed 2004·Granted Nov 7, 2006·220 cites·262 claims
- 0498US7109003B2Methods for expressing and recovering human monoclonal antibodies to CTLA-4PFIZER·Filed 2003·Granted Sep 19, 2006·287 cites·101 claims
- 0598US6682736B1Human monoclonal antibodies to CTLA-4ABGENIX INC·Filed 1999·Granted Jan 27, 2004·776 cites·104 claims
- 0697US8883984B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2013·Granted Nov 11, 2014·38 cites·24 claims
- 0797US8491895B2Methods of treating cancer with human monoclonal antibodies to CTLA-4HANSON DOUGLAS CHARLES·Filed 2012·Granted Jul 23, 2013·99 cites·20 claims
- 0897US8143379B2Human monoclonal antibodies to CTLA-4HANSON DOUGLAS CHARLES·Filed 2007·Granted Mar 27, 2012·121 cites·22 claims
- 0997US7807797B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2007·Granted Oct 5, 2010·76 cites·25 claims
- 1091US9963508B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2014·Granted May 8, 2018·6 cites·13 claims
- 1185US8198251B2Combination motif immune stimulatory oligonucleotides with improved activityVOLLMER JORG·Filed 2008·Granted Jun 12, 2012·11 cites·1 claims
- 1263US2009117132A1Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer TreatmentPFIZER·Filed 2006·Application pending·0 cites
- 1355US2012003179A1Anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatmentREADETT DAVID ROBERT JOHN·Filed 2011·Application pending·0 cites
- 1448US2003086930A1Uses of anti-CTLA-4 antibodiesFiled 2002·Application pending·0 cites
- 1544US2012219571A1Combination motif immune stimulatory oligonucleotides with improved activityVOLLMER JORG·Filed 2012·Application pending·0 cites
- 1642US2005226875A1Uses of anti-CTLA-4 antibodiesPFIZER·Filed 2005·Application pending·0 cites
- 1733US5192790A3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesisPFIZER·Filed 1991·Granted Mar 9, 1993·1 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Douglas Charles Hanson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →